<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The authors describe an infant with abnormal development of the cerebral venous system associated with in utero <z:hpo ids='HP_0002119'>ventriculomegaly</z:hpo> and perinatal <z:mp ids='MP_0001914'>hemorrhage</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>When the patient was 6 weeks of age <z:hpo ids='HP_0007100'>progressive ventriculomegaly</z:hpo> followed by cerebrospinal fluid diversion resulted in tumefaction of the dural sinuses, intravascular <z:mp ids='MP_0005048'>thrombosis</z:mp>, and a <z:hpo ids='HP_0003256'>coagulopathy</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Oral anticoagulation therapy safely reversed the <z:hpo ids='HP_0003256'>coagulopathy</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Serial neuroimaging findings in this unique cascade of pathophysiological events indicated that, despite decreased intracranial pressure after shunt placement, local hemodynamic factors increased the venous resistance to flow and prolonged the transit time </plain></SENT>
<SENT sid="4" pm="."><plain>Long-term anticoagulation therapy was associated with improvements in flow, transit time, and tumefaction </plain></SENT>
</text></document>